EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings

Nicolas Garel, Julien Thibault Lévesque, Dasha A Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T Greenway

Frontiers in Human Neuroscience · 18.07.2023 · 17

DOI: 10.3389/fnhum.2023.1200393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 18.07.2023. Verfasst von Nicolas Garel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, McGill University, Montreal, QC, Canada. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psychedelic drug experiences are shaped by current-moment contextual factors, commonly categorized as internal (set) and external (setting). Potential influences of past environments, however, have received little attention.

Aims

To investigate how previous environmental stimuli shaped the experiences of patients receiving ketamine for treatment-resistant depression (TRD), and develop the concept of “imprinting” to account for such time-lagged effects across diverse hallucinogenic drugs.

Methods

Recordings of treatment sessions and phenomenological interviews from 26 participants of a clinical trial investigating serial intravenous ketamine infusions for TRD, conducted from January 2021 to August 2022, were retrospectively reviewed. A broad literature search was undertaken to identify potentially underrecognized examples of imprinting with both serotonergic and atypical psychedelics, as well as analogous cognitive processes and neural mechanisms.

Results

In naturalistic single-subject experiments of a 28-year-old female and a 34-year-old male, subjective ketamine experiences were significantly altered by varying exposures to particular forms of digital media in the days preceding treatments. Higher levels of media exposure reduced the mystical/emotional qualities of subsequent psychedelic ketamine experiences, overpowering standard intention-setting practices and altering therapeutic outcomes. Qualitative data from 24 additional patients yielded eight further spontaneous reports of past environmental exposures manifesting as visual hallucinations during ketamine experiences. We identified similar examples of imprinting with diverse psychoactive drugs in past publications, including in the first-ever report of ketamine in human subjects, as well as analogous processes known to underly dreaming. Conclusions/interpretation Past environmental exposures can significantly influence the phenomenology and therapeutic outcomes of psychedelic experiences, yet are underrecognized and understudied. To facilitate future research, we propose expanding the contextual model of psychedelic drug actions to incorporate imprinting, a novel concept that may aid clinicians, patients, and researchers to better understand psychedelic drug effects. Clinical trial registration ClinicalTrials.gov , identifier NCT04701866.

Schlagwörter

Stichwörter der Autor:innen

dreamingextra-pharmacological modelhallucinationsimprintingketaminepreparationpsychedelicsset and setting

Autor:innen und Institutionen

  • Department of Psychiatry, McGill University, Montreal, QC, Canada.
  • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
  • Department of Psychology, McGill University, Montreal, QC, Canada.
  • Integrated Program in Neurosciences, McGill University, Montreal, QC, Canada.
  • Neurophilosophy Lab, Department of Philosophy, McGill University, Montreal, QC, Canada.
  • McGill Group for Suicide Studies, Douglas Mental Health University Institute, LaSalle, QC, Canada.

Zitieren

APA

Garel, N., Thibault Lévesque, J., Sandra, D. A., Lessard-Wajcer, J., Solomonova, E., Lifshitz, M., Richard-Devantoy, S., & Greenway, K. T. (2023). Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings. Frontiers in Human Neuroscience, 17. https://doi.org/10.3389/fnhum.2023.1200393

Vancouver

Garel N, Thibault Lévesque J, Sandra DA, Lessard-Wajcer J, Solomonova E, Lifshitz M, et al. Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings. Frontiers in Human Neuroscience. 2023;17. doi:10.3389/fnhum.2023.1200393

BibTeX
@article{Garel2023,
  author = {Garel, Nicolas and Thibault Lévesque, Julien and Sandra, Dasha A and Lessard-Wajcer, Justin and Solomonova, Elizaveta and Lifshitz, Michael and Richard-Devantoy, Stéphane and Greenway, Kyle T},
  title = {Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings},
  journal = {Frontiers in Human Neuroscience},
  year = {2023},
  volume = {17},
  doi = {10.3389/fnhum.2023.1200393}
}
Kostenlos starten →